Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls
Open accessThe DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Abstract
Extensive research has shown that increased production of reactive oxygen species (ROS) results in tissue injury under a variety of pathological conditions and chronic degenerative diseases. While ROS are highly reactive and can incite significant injury, polyunsaturated lipids in membranes and lipoproteins are their main targets. ROS-triggered lipid peroxidation reactions generate a range of reactive carbonyl species (RCS), and these RCS spread and amplify ROS-related injury. Several RCS generated in oxidizing lipids, such as 4-hydroxy trans-2-nonenal (HNE), 4-oxo-2-(E)-nonenal (ONE), acrolein, malondialdehyde (MDA) and phospholipid aldehydes have been shown to be produced under conditions of oxidative stress and contribute to tissue injury and dysfunction by depleting glutathione and other reductants leading to the modification of proteins, lipids, and DNA. To prevent tissue injury, these RCS are metabolized by several oxidoreductases, including members of the aldo-keto reductase (AKR) superfamily, aldehyde dehydrogenases (ALDHs), and alcohol dehydrogenases (ADHs). Metabolism via these enzymes results in RCS inactivation and detoxification, although under some conditions, it can also lead to the generation of signaling molecules that trigger adaptive responses. Metabolic transformation and detoxification of RCS by oxidoreductases prevent indiscriminate ROS toxicity, while at the same time, preserving ROS signaling. A better understanding of RCS metabolism by oxidoreductases could lead to the development of novel therapeutic interventions to decrease oxidative injury in several disease states and to enhance resistance to ROS-induced toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · cited 2×
“Once formed, HNE undergoes a series of reactions that can result in the formation of covalent adducts with lysine residues of lipoproteins [3, 4].”
BackgroundGinestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357 · cited 1×
“Such ROS-mediated injury is a significant feature of several disease states such as diabetes, cardiovascular diseases, hypertension [1] and Alzheimer’s disease [2].”
BackgroundMechanisms of free radical oxidation of unsaturated lipids
Porter, N. A., Caldwell, S. E., & Mills, K. A. (1995) · Lipids · doi:10.1007/bf02536034 · Cited by 1,208 · cited 2×
“The basic mechanism of autoxidation has been extensively reviewed in the literature [6, 7].”
BackgroundLipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006 · cited 3×
“The basic mechanism of autoxidation has been extensively reviewed in the literature [6, 7].”
BackgroundReactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824 · cited 1×
“Such ROS-mediated injury is a significant feature of several disease states such as diabetes, cardiovascular diseases, hypertension [1] and Alzheimer’s disease [2].”
BackgroundAldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Jiang, F., Qiu, Q., Khanna, A., Todd, N. W., Deepak, J., Xing, L., Wang, H., Liu, Z., Su, Y., Stass, S. A., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0393 · Cited by 788
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784 · cited 1×
“The levels of oxidized phospholipids bound to lipoproteins correlated with the extent of angiographically-documented atherosclerotic disease [43] indicating that oxidized phospholipids may be involved in the formation of atherosclerotic lesions [44].”
BackgroundEhara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1955 · Cited by 781 · cited 1×
“MDA-modified LDL has been shown to accumulate in atherosclerotic lesions, and a growing body of evidence indicates that oxidized LDL is involved in the pathogenesis of coronary artery disease (CAD), acute coronary syndrome (ACS), and vulnerable plaques [40].”
BackgroundCharafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men.
Thomasson, H. R., Edenberg, H. J., Crabb, D. W., L, X., Jerome, R. E., Li, T., Wang, S. P., Lin, Y. T., Lu, R., & Yin, S. (1991) · PubMed Central · Cited by 664
Protein-bound acrolein: Potential markers for oxidative stress
Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4882 · Cited by 632 · cited 1×
“It is also generated by the oxidation of unsaturated lipids [33].”
BackgroundTargeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614 · cited 1×
“Furthermore, an ALDH2 inactivating mutation (ALDH2*2) was found to be the most common single point mutation in humans responsible to alcohol intolerance, and epidemiological evidence suggests a strong correlation between this inactivating mutation and increased propensity for common human pathologies [135].”
BackgroundThe aldo-keto reductases (AKRs): Overview
Penning, T. M. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.024 · Cited by 543 · cited 1×
“They contain the conserved NADP(H) binding domain and exist as tetramers [91].”
BackgroundCrabb, D. W., Matsumoto, M., Chang, D., & You, M. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2003327 · Cited by 521 · cited 1×
“The mutation related deficiency is manifested by slow acetaldehyde removal with low alcohol tolerance [137, 138].”
BackgroundMarnett, L. J., Riggins, J. N., & West, J. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18022 · Cited by 476 · cited 1×
“Once formed, HNE undergoes a series of reactions that can result in the formation of covalent adducts with lysine residues of lipoproteins [3, 4].”
BackgroundThe Aldo-Keto Reductase Superfamily
Bohren, K. M., Bullock, B., Wermuth, B., & Gabbay, K. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60566-6 · Cited by 453
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Rasheed, Z. A., Yang, J., Wang, Q., Kowalski, J., Freed, I., Murter, C., Hong, S.-M., Koorstra, J.-B., Rajeshkumar, N. V., He, X., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp535 · Cited by 437
Deng, S., Yang, X., Lassus, H., Liang, S., Kaur, S., Ye, Q., Li, C., Wang, L.-P., Roby, K. F., Orsulic, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010277 · Cited by 415 · cited 2×
“Interestingly, a higher ALDH activity is detected in stem cells and progenitor cells and it has been hypothesized that such activity can also be detected in cancer stem cells [121].”
BackgroundThe role of oxidized phospholipids in atherosclerosis
Berliner, J. A., Leitinger, N., & Tsimikas, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800074-jlr200 · Cited by 403
Anderson, M. M., Hazen, S. L., Hsu, F. F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 389 · cited 1×
“In addition, acrolein is generated endogenously by the degradation of polyamines or by myeloperoxidase [32] present in neutrophils.”
BackgroundAldo-Keto Reductases and Bioactivation/Detoxication
Jin, Y., & Penning, T. M. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 383 · cited 2×
“Three families of the AKR superfamily are comprised of mammalian proteins (AKR1, AKR6 and AKR7) [45] and are discussed individually in the following sub-sections.”
BackgroundTargeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Landen, C. N., Goodman, B., Katre, A. A., Steg, A. D., Nick, A. M., Stone, R. L., Miller, L. D., Mejia, P. V., Jennings, N. B., Gershenson, D. M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0563 · Cited by 382
Li, T., Su, Y., Mei, Y., Leng, Q., Leng, B., Liu, Z., Stass, S. A., & Jiang, F. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.127 · Cited by 362
Aldehyde dehydrogenase gene superfamily: the 2002 update
Sophos, N. A., & Vasiliou, V. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00163-1 · Cited by 335 · cited 1×
“Twenty one gene families have been identified in eukaryotes [115] and at least 17 genes encoding members of these enzymes have been found in humans.”
BackgroundStructure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion
Steinmetz, C. G., Xie, P., Weiner, H., & Hurley, T. D. (1997) · Structure · doi:10.1016/s0969-2126(97)00224-4 · Cited by 324 · cited 14×
“The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.”
BackgroundInfluentialRole of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism
Vasiliou, V., Pappa, A., & Estey, T. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120034001 · Cited by 308 · cited 1×
“The human gene families have been arranged into 10 families and 13 sub-families [118].”
BackgroundAge-associated analysis of oxidative stress parameters in human plasma and erythrocytes
Gil, L., Siems, W., Mazurek, B., Gross, J., Schroeder, P., Voss, P., & Grune, T. (2006) · Free Radical Research · doi:10.1080/10715760600592962 · Cited by 242 · cited 1×
“7 μM [9], but can increase significantly during aging [10] and in diseases associated with oxidative stress [11], when HNE levels can range from 1–20 μM.”
BackgroundCharacterization of 4-Oxo-2-nonenal as a Novel Product of Lipid Peroxidation
Lee, S. H., & Blair, I. A. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000101a · Cited by 242 · cited 1×
“As a direct product of lipid-oxidation [27, 28] it arises independently from the same hydroperoxide precursor.”
BackgroundProtein Damage by Reactive Electrophiles: Targets and Consequences
Liebler, D. C. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700235t · Cited by 237
Inhibition of NADH-Linked Mitochondrial Respiration by 4-Hydroxy-2-nonenal
Humphries, K. M., Yoo, Y., & Szweda, L. I. (1998) · Biochemistry · doi:10.1021/bi971958i · Cited by 231 · cited 1×
“At concentrations comparable to their in vivo levels, RCS impair a variety of cellular processes [7] such as energy production [178], calcium homeostasis and ion channel activity [179].”
BackgroundGhilarducci, D. P., & Tjeerdema, R. S. (1995) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4612-2550-8_2 · Cited by 230 · cited 3×
“Acrolein is also present in beverages and foods including coffee, alcohol, cheese, and donuts; and it has been shown that heating and cooking of fats, oils and sugars increases their acrolein content [31].”
BackgroundInfluentialA Role for Oxidized Phospholipids in Atherosclerosis
Berliner, J. A., & Watson, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058118 · Cited by 229 · cited 1×
“The levels of oxidized phospholipids bound to lipoproteins correlated with the extent of angiographically-documented atherosclerotic disease [43] indicating that oxidized phospholipids may be involved in the formation of atherosclerotic lesions [44].”
BackgroundVasiliou, V., Bairoch, A., Tipton, K. F., & Nebert, D. W. (1999) · PubMed · Cited by 222
Patel, M., Lu, L., Zander, D. S., Sreerama, L., Coco, D., & Moreb, J. S. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.08.033 · Cited by 220
O'CONNOR, T., IRELAND, L. S., HARRISON, D. J., & HAYES, J. D. (1999) · Biochemical Journal · doi:10.1042/bj3430487 · Cited by 217 · cited 1×
“AKR7A2 is present in several tissues including brain, liver, and kidney [108].”
BackgroundSubbanagounder, G., Leitinger, N., Schwenke, D. C., Wong, J. W., Lee, H., Rizza, C., Watson, A. D., Faull, K. F., Fogelman, A. M., & Berliner, J. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2248 · Cited by 216 · cited 1×
“Previous studies have shown that aortae obtained from rabbits fed an atherogenic diet contained higher levels of POVPC, PGPC and PEIPC than those from rabbits fed with the control diet [42].”
ResultBoleda, M. D., Saubi, N., Farres, J., & Pares, X. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1564 · Cited by 213 · cited 3×
“Class IV also plays a crucial role in the generation of retinoic acid in epithelia, where this metabolite is involved in development and cell differentiation [161].”
BackgroundSládek, N. E., Kollander, R., Sreerama, L., & Kiang, D. T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0412-4 · Cited by 212 · cited 2×
“Whereas breast cancer patients treated with cyclophosphamide revealed high levels of ALDH1A1 in metastatic tumor cells that survived exposure to cyclophosphamide and in metastatic tumors that did not respond to cyclophosphamide treatment [132], demonstrating further a causal role of ALDH1A1 in developing chemo resista…”
BackgroundVäkeväinen, S., Tillonen, J., Agarwal, D. P., Srivastava, N., & Salaspuro, M. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02068.x · Cited by 211 · cited 1×
“ALDH2—ALDH2 is located in the mitochondrial matrix and has been extensively studied within the context of several important human pathologies such as cardiovascular diseases, diabetes, neurodegenerative diseases, stroke, and cancer [133].”
BackgroundWatson, A. D., Subbanagounder, G., Welsbie, D. S., Faull, K. F., Navab, M., Jung, M. E., Fogelman, A. M., & Berliner, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24787 · Cited by 206 · cited 5×
“Time course analysis revealed that the reduced products reached significant levels for ions at m/z 594/596 (POVPC/ PHVPC), 810/812 (PECPC/2H-PECPC) and 828/830 (PEI-PC/2H-PEIPC) in the oxPA-PC +Kvβ2 mixture.”
InfluentialAldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis
Rittner, H. L., Hafner, V., Klimiuk, P. A., Szweda, L. I., Goronzy, J. J., & Weyand, C. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4711 · Cited by 205 · cited 2×
“In agreement with an important role of AR in RCS metabolism and detoxification, it has been shown that exposure to RCS such as HNE results in rapid induction of AR synthesis in monocytes [67].”
BackgroundMoreb, J. S., Ucar, D., Han, S., Amory, J. K., Goldstein, A. S., Ostmark, B., & Chang, L.-J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.10.007 · Cited by 203 · cited 2×
“In lung cancers and leukemia cells an overexpression of ALDH1A1 was described [131] whereas in cyclophosphamide treated breast cancer patients, a high ALDH1A1 was revealed in metastatic tumor cells that survived [132] thereby suggesting a potential role of ALDH1A1 in the resistance of cells to chemotherapy.”
BackgroundAldehydic lipid peroxidation products derived from linoleic acid
Spiteller, P. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00100-7 · Cited by 201 · cited 1×
“As a direct product of lipid-oxidation [27, 28] it arises independently from the same hydroperoxide precursor.”
BackgroundBurczynski, M. E., Sridhar, G. R., Palackal, N. T., & Penning, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006655200 · Cited by 190
Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.
Hoff, H. F., O'Neil, J., Chisolm, G. M., Cole, T. B., Quehenberger, O., Esterbauer, H., & Jürgens, G. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.4.538 · Cited by 189 · cited 1×
“Because the formation of such adducts alters the charge distribution in the lipoprotein, the modified protein is recognized and engulfed by macrophages [14].”
BackgroundGallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I., & Parés, X. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705659105 · Cited by 182 · cited 1×
“However, the best substrates for AKR1B10 are retinals [58] but the enzyme may also be involved in the metabolism of biogenic aldehydes [84] as well as the removal of toxic aldehydes, in general.”
BackgroundKhanna, M., Qin, K.-N., Wang, R. W., & Cheng, K.-C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20162 · Cited by 174 · cited 1×
“AKR1C3—AKR1C3 is a key steroidogenic enzyme [86, 87] that catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9-α, 11-β-PGF2 to PGD2.”
BackgroundSchauenstein, E. (1967) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38899-4 · Cited by 173
Structural and Kinetic Determinants of Aldehyde Reduction by Aldose Reductase
Srivastava, S., Watowich, S. J., Petrash, J. M., Srivastava, S. K., & Bhatnagar, A. (1999) · Biochemistry · doi:10.1021/bi981794l · Cited by 173
Self-citationMatsuura, K., Shiraishi, H., Hara, A., Sato, K., Deyashiki, Y., Ninomiya, M., & Sakai, S. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022211 · Cited by 172 · cited 1×
“AKR1C3—AKR1C3 is a key steroidogenic enzyme [86, 87] that catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9-α, 11-β-PGF2 to PGD2.”
BackgroundALDH3A1: a corneal crystallin with diverse functions
Estey, T., Piatigorsky, J., Lassen, N., & Vasiliou, V. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.010 · Cited by 169 · cited 1×
“Since ALDH3A1 is expressed abundantly in corneal epithelium [153] it is considered to play a role in maintaining the corneal function of light transparency and refraction [154].”
Background4-Oxo-2-nonenal Is Both More Neurotoxic and More Protein Reactive than 4-Hydroxy-2-nonenal
Lin, D., Lee, H.-G., Liu, Q., Perry, G., Smith, M. A., & Sayre, L. M. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050080q · Cited by 164 · cited 3×
“reactive and cytotoxic agent than HNE and more reactive as a protein cross linking reagent than HNE [25].”
BackgroundKelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., & Hayes, J. D. (2000) · PubMed · Cited by 164
Srivastava, S., Chandra, A., Bhatnagar, A., Srivastava, S. K., & Ansari, N. H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2835 · Cited by 161 · cited 1×
“AR has been shown to catalyse the reduction of HNE and related aldehydes as well as their glutathionyl conjugates [63, 64].”
BackgroundSelf-citationALDH1 expression correlates with favorable prognosis in ovarian cancers
Chang, B., Liu, G., Xue, F., Rosen, D. G., Xiao, L., Wang, X., & Liu, J. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.35 · Cited by 157
PAPPA, A., ESTEY, T., MANZER, R., BROWN, D., & VASILIOU, V. (2003) · Biochemical Journal · doi:10.1042/bj20030810 · Cited by 154 · cited 2×
“The kinetic parameters for ALDH3A1 with respect to HNE metabolism were found to be in the range of 45 ± 18 μM [153].”
BackgroundHoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M., & Lewis, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2517 · Cited by 137 · cited 1×
“The substrate specificity is dependent on three flexible loops (A, B, and C) [46].”
BackgroundRamana, K. V., Bhatnagar, A., Srivastava, S., Yadav, U. C., Awasthi, S., Awasthi, Y. C., & Srivastava, S. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600270200 · Cited by 137 · cited 1×
“However, the effect of GS-DHN was not prevented by AR inhibitors [70] suggesting that reduction of GS-HNE to GS-DHN by AR is essential for NF-κB activation.”
BackgroundSelf-citationPappa, A., Chen, C., Koutalos, Y., Townsend, A. J., & Vasiliou, V. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00070-4 · Cited by 137 · cited 1×
“2 [141] and have been reported to have multiple functions including the maintenance of hematopoietic stem cells, protection of the eye from UV radiation [142], regulating cell proliferation and lipid-peroxidation mediated growth inhibition [143], in Singh et al.”
BackgroundHuman Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression
Tsimikas, S., Miyanohara, A., Hartvigsen, K., Merki, E., Shaw, P. X., Chou, M.-Y., Pattison, J., Torzewski, M., Sollors, J., Friedmann, T., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.017 · Cited by 125 · cited 1×
“The tissue antigens can serve as potential key candidates for use in characterizing immune responses relevant to atherogenesis [37, 38].”
BackgroundEllis, E. M., Judah, D. J., Neal, G. E., & Hayes, J. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10350 · Cited by 123 · cited 1×
“Furthermore, it was demonstrated that AKR7A1 is capable of detoxifying aflatoxin B1 (AFB1), a hepatocarcinogen [104, 105].”
BackgroundCatalytic Properties of Human Liver Alcohol Dehydrogenase Isoenzymes
BOSRON, W. F., & Li, T. (2017) · Enzyme · doi:10.1159/000469238 · Cited by 122 · cited 1×
“All known isoenzymes (homodimeric and heterodimeric) have been isolated and purified to homogeneity [162, 163].”
BackgroundGalligan, J. J., Rose, K. L., Beavers, W. N., Hill, S., Tallman, K. A., Tansey, W. P., & Marnett, L. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503604t · Cited by 118
Ohsawa, I., Nishimaki, K., Murakami, Y., Suzuki, Y., Ishikawa, M., & Ohta, S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4956-07.2008 · Cited by 117 · cited 1×
“Recent studies suggested that ALDH2 dysfunction is associated with Fanconi anemia, pain, osteoporosis, and aging [134].”
BackgroundHayes, J. D., Judah, D. J., & Neal, G. E. (1993) · PubMed · Cited by 117
Gabbay, K. H., Bohren, K. M., Morello, R., Bertin, T., Liu, J., & Vogel, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110247 · Cited by 114 · cited 1×
“The enzyme catalyzes the reduction of D-glucuronic acid and D-glucurono-γ-lactone during ascorbic acid biosynthesis and genetic deletion of this enzyme in mice results in severe osteopenia and spontaneous fractures due to ascorbic acid deficiency [53, 54].”
Background4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells
Herbst, U., Toborek, M., Kaiser, S., Mattson, M. P., & Hennig, B. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2<295::aid-jcp11>3.0.co;2-i · Cited by 113 · cited 1×
“In vitro incubation of vascular cells with PUFAs such as linoleic and arachidonic acid directly increases HNE formation [12] .”
BackgroundDuryee, M. J., Klassen, L. W., Schaffert, C. S., Tuma, D. J., Hunter, C. D., Garvin, R. P., Anderson, D. R., & Thiele, G. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.001 · Cited by 110 · cited 1×
“The tissue antigens can serve as potential key candidates for use in characterizing immune responses relevant to atherogenesis [37, 38].”
BackgroundRole of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes
Martin, H.-J., & Maser, E. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.021 · Cited by 109 · cited 1×
“However, the best substrates for AKR1B10 are retinals [58] but the enzyme may also be involved in the metabolism of biogenic aldehydes [84] as well as the removal of toxic aldehydes, in general.”
BackgroundAldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain
Zambelli, V. O., Gross, E. R., Chen, C.-H., Gutierrez, V. P., Cury, Y., & Mochly-Rosen, D. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009539 · Cited by 107 · cited 1×
“In support of this concept, it has been recently shown that knock-in of ALDH2*2 in mice heighten nociception, which could be attenuated upon treatment with Alda-1, suggesting that treatment with Alda-1 could increase pain tolerance in individuals carrying the ALDH2 point mutation [140].”
BackgroundModel Studies on Protein Side Chain Modification by 4-Oxo-2-nonenal
Zhang, W., Liu, J., Xu, G., Yuan, Q., & Sayre, L. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx020105a · Cited by 107 · cited 1×
“In addition, ONE forms simple 4-ketoaldehyde Michael adducts that can exist as such or undergo Paal Knorr condensation [21].”
BackgroundPappa, A., Brown, D., Koutalos, Y., DeGregori, J., White, C., & Vasiliou, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503698200 · Cited by 106
Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A. V., & Sayre, L. M. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000007u · Cited by 103 · cited 1×
“Such HNE-modified proteins have been demonstrated in atherosclerotic plaques [15] and the modification of lipoproteins by HNE and related RCS have been suggested to be the key initiating event in atherosclerotic lesion formation [16].”
BackgroundLiu, Z., Minkler, P. E., & Sayre, L. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx0300030 · Cited by 101 · cited 1×
“The crosslink products are quite stable and have been detected in proteins [22, 23].”
BackgroundSubstrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes
Spite, M. R., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A., & Srivastava, S. (2007) · Biochemical Journal · doi:10.1042/bj20061743 · Cited by 101 · cited 2×
“In vitro, the purified enzyme is capable of catalyzing the reduction of both free and phospholipid bound aldehydes [66], therefore AKR1B8 could act as a physiological scavenger of toxic RCS (Table 1) derived from lipid-peroxidation in several tissues where it is expressed [80].”
BackgroundSelf-citationShen, Y., Zhong, L., Johnson, S. R., & Cao, D. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.02.004 · Cited by 101 · cited 1×
“These results suggest that AKR1B10 is more effective in eliminating RCS, but AKR1B1 seems more important for the detoxification of glutathione-conjugated carbonyl compounds [83].”
BackgroundRuef, J., Liu, S.-Q., Bode, C., Tocchi, M., Srivastava, S., Runge, M. S., & Bhatnagar, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1745 · Cited by 96 · cited 1×
“A similar role of RCS could be postulated in the formation of neointimal lesions as treatment with AR inhibitors has been shown to prevent neointimal lesions in balloon-injured arteries [69].”
BackgroundSelf-citationChrostek, L., Jelski, W., Szmitkowski, M., & Puchalski, Z. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10076 · Cited by 93 · cited 1×
“For example, ADH isoenzyme activities have been measured in the livers of male and female patients and total ADH and class I and II activities were found to be significantly higher in males than in females [174, 175].”
Selley, M. L., Bartlett, M., McGuiness, J. A., Hapel, A. J., Ardlie, N. G., & Lacey, M. J. (1989) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82957-6 · Cited by 90 · cited 1×
“7 μM [9], but can increase significantly during aging [10] and in diseases associated with oxidative stress [11], when HNE levels can range from 1–20 μM.”
BackgroundAldehyde dehydrogenase gene superfamily: the 2000 update
Sophos, N. A., Pappa, A., Ziegler, T. L., et al. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00275-1 · Cited by 90
Ireland, L. S., Harrison, D. J., Neal, G. E., & Hayes, J. D. (1998) · Biochemical Journal · doi:10.1042/bj3320021 · Cited by 87
Selective Recognition of Glutathiolated Aldehydes by Aldose Reductase
Ramana, K. V., Dixit, B. L., Srivastava, S., Balendiran, G. K., Sk, S., & Bhatnagar, A. (2000) · Biochemistry · doi:10.1021/bi000796e · Cited by 87
Self-citationAlkylation Damage by Lipid Electrophiles Targets Functional Protein Systems
Codreanu, S. G., Cantu, J. C., Zhu, J., Tallman, K. A., Beavers, W. N., Porter, N. A., Marnett, L. J., Zhang, B., & Liebler, D. C. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032953 · Cited by 87 · cited 1×
“Recent work has also shown that damage caused by alkylation may be selective, where certain functional protein networks (such as the cytoskeleton) are more sensitive than other networks such as those involved in protein synthesis and turnover [180].”
BackgroundPollack, M., Oe, T., Lee, S. H., Elipe, M. V. S., Arison, B. H., & Blair, I. A. (2003) · Chemical Research in Toxicology · doi:10.1021/tx030009p · Cited by 81 · cited 1×
“Like HNE, ONE readily modifies DNA bases [29, 30].”
BackgroundJang, J.-H., Bruse, S., Liu, Y., Duffy, V., Zhang, C., Oyamada, N., Randell, S. H., Matsumoto, A., Thompson, D. C., Lin, Y., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.028 · Cited by 81 · cited 1×
“Multiple isoforms were studied and it was found that the ALDH3A1 enzyme displays the most drastic upregulation, though ALDH1A3, ALDH2, ALDH3A2, ALDH3B1, ALDH5A1, ALDH19A1, ALDH16A1 and ALDH18A1 were also upregulated [152].”
BackgroundBhatnagar, A. (1995) · Circulation Research · doi:10.1161/01.res.76.2.293 · Cited by 80 · cited 1×
“At concentrations comparable to their in vivo levels, RCS impair a variety of cellular processes [7] such as energy production [178], calcium homeostasis and ion channel activity [179].”
BackgroundSelf-citationTownsend, A. J., Leone‐Kabler, S., Haynes, R. L., Wu, Y., Szweda, L. I., & Bunting, K. D. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00270-2 · Cited by 80 · cited 2×
“In previous studies, ALDH3A1 expression has been studied in V79 cells, where an increase in the expression of ALDH3A1 led to a dramatic decrease in HNE adducts formation and apoptosis [155, 156].”
BackgroundAntioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts
Lassen, N., Pappa, A., Black, W. J., Jester, J. V., Day, B. J., Min, E., & Vasiliou, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.009 · Cited by 79 · cited 1×
“attenuating ROS induced protein modification [144], preventing DNA damage and apoptosis [145] and providing resistance against chemotherapeutic drugs [143, 146–152].”
BackgroundChoudhary, S., Xiao, T., Vergara, L. A., Srivastava, S., Nees, D., Piatigorsky, J., & Ansari, N. H. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0120 · Cited by 78 · cited 1×
“Furthermore, ablation of ALDH1A1 led to a decrease in the ability of human lens epithelial cells to oxidize HNE, as measured by cell viability and apoptosis assays [124].”
BackgroundCoexpression of the KCNA3BGene Product with Kv1.5 Leads to a Novel A-type Potassium Channel
Leicher, T., Bähring, R., Isbrandt, D., & Pongs, O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35095 · Cited by 77 · cited 1×
“These subunits regulate the gating properties of the channel and assist in channel trafficking and membrane localization [90].”
BackgroundThe Role of α,β-Dicarbonyl Compounds in the Toxicity of Short Chain Sugars
Okado‐Matsumoto, A., & Fridovich, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005536200 · Cited by 77
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
Yan, J., Melo, J. D., Cutz, J.-C., Aziz, T., & Tang, D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.201 · Cited by 77 · cited 1×
“Besides its role in lipid-peroxidation, an increase in ALDH3A1 has been shown to be associated with prostate carcinoma where increased level of ALDH3A1 correlated with an increased severity of prostate cancer [160].”
BackgroundA Novel Lipid Hydroperoxide-derived Cyclic Covalent Modification to Histone H4
Oe, T., Arora, J. S., Lee, S. H., & Blair, I. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308167200 · Cited by 75 · cited 1×
“The crosslink products are quite stable and have been detected in proteins [22, 23].”
BackgroundEndogenous Lipid Hydroperoxide-mediated DNA-adduct Formation in Min Mice
Williams, M. V., Lee, S. H., Pollack, M., & Blair, I. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600178200 · Cited by 74 · cited 1×
“Like HNE, ONE readily modifies DNA bases [29, 30].”
BackgroundSrivastava, S., Vladykovskaya, E. N., Barski, O. A., Spite, M. R., Kaiserová, K., Petrash, J. M., Chung, S. S. M., Hunt, G., Dawn, B., & Bhatnagar, A. (2009) · Circulation Research · doi:10.1161/circresaha.109.200568 · Cited by 71 · cited 1×
“Such HNE-modified proteins have been demonstrated in atherosclerotic plaques [15] and the modification of lipoproteins by HNE and related RCS have been suggested to be the key initiating event in atherosclerotic lesion formation [16].”
BackgroundSelf-citationXu, G., & Sayre, L. M. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980003d · Cited by 70 · cited 1×
“Like HNE, it reacts with nucleophilic side chain of proteins and generates products in higher yields than HNE [20].”
BackgroundAldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
Srivastava, S., Spite, M. R., Trent, J. O., West, M., Ahmed, Y., & Bhatnagar, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403416200 · Cited by 69 · cited 8×
“Time course analysis revealed that the reduced products reached significant levels for ions at m/z 594/596 (POVPC/ PHVPC), 810/812 (PECPC/2H-PECPC) and 828/830 (PEI-PC/2H-PEIPC) in the oxPA-PC +Kvβ2 mixture.”
BackgroundInfluentialSelf-citationAldo-Keto Reductases 1B in Endocrinology and Metabolism
Pastel, E., Pointud, J., Volat, F., Martinez, A., & Lefrançois‐Martinez, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00148 · Cited by 69 · cited 2×
“In vitro, the purified enzyme is capable of catalyzing the reduction of both free and phospholipid bound aldehydes [66], therefore AKR1B8 could act as a physiological scavenger of toxic RCS (Table 1) derived from lipid-peroxidation in several tissues where it is expressed [80].”
BackgroundSrivastava, S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00454-3 · Cited by 69 · cited 1×
“AR has been shown to catalyse the reduction of HNE and related aldehydes as well as their glutathionyl conjugates [63, 64].”
BackgroundSubstrate specificity of an aflatoxin-metabolizing aldehyde reductase
Ellis, E. M., & Hayes, J. D. (1995) · Biochemical Journal · doi:10.1042/bj3120535 · Cited by 68 · cited 2×
“Analogous to several aldo-keto reductases, AKR7A1 enzyme has also been shown to catalyze the reaction between reactive aldehydes including α-unsaturated carbonyl compounds to alcohols [103].”
BackgroundHintz, K. K., Relling, D. P., Saari, J. T., Borgerding, A. J., Duan, J., Ren, B. H., Kato, K., Epstein, P. N., & Ren, J. T. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075823.73536.dd · Cited by 68 · cited 2×
“These result suggested that increased cardiac acetaldehyde exposure due to ADH transgene may play an important role in cardiac contractile dysfunctions associated with lipid and protein damage after alcohol intake [167].”
BackgroundO'Connor, T., Ireland, L. S., Harrison, D. J., et al. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430487 · Cited by 66
Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease
Picklo, M. J., Olson, S. J., Hayes, J. D., Markesbery, W. R., & Montine, T. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02897-9 · Cited by 62 · cited 1×
“Accumulation of AKR7A2 in specific regions of the brain in Alzheimer’s disease has been shown [109].”
BackgroundMolecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal
Black, W., Chen, Y., Matsumoto, A., Thompson, D. C., Lassen, N., Pappa, A., & Vasiliou, V. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.050 · Cited by 60 · cited 1×
“In previous studies, ALDH3A1 expression has been studied in V79 cells, where an increase in the expression of ALDH3A1 led to a dramatic decrease in HNE adducts formation and apoptosis [155, 156].”
BackgroundMuzio, G., Trombetta, A., Maggiora, M., Martinasso, G., Vasiliou, V., Lassen, N., & Canuto, R. A. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.020 · Cited by 60
Selley, M. L. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00446-x · Cited by 59 · cited 1×
“7 μM [9], but can increase significantly during aging [10] and in diseases associated with oxidative stress [11], when HNE levels can range from 1–20 μM.”
BackgroundTipparaju, S. M., Barski, O. A., Srivastava, S., & Bhatnagar, A. (2008) · Biochemistry · doi:10.1021/bi800301b · Cited by 58 · cited 1×
“It has been recently shown that Kvβ2 catalyzes the reduction of a broad range of compounds such as aromatic carbonyls, electrophilic aldehydes and prostaglandins [94].”
BackgroundSelf-citationAKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
Tian, Y., Zhao, L., Zhang, H., Liu, X., Zhao, L., Zhao, X., Li, Y., & Li, J. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-42 · Cited by 57 · cited 1×
“overexpression may serve as a potential biomarker for prostate cancer progression [88].”
BackgroundSynthesis and Catabolism of γ-Hydroxybutyrate in SH-SY5Y Human Neuroblastoma Cells
Lyon, R. C., Johnston, S. M., Watson, D. G., McGarvie, G. M., & Ellis, E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702465200 · Cited by 57 · cited 1×
“AKR7A2—It was identified as a human brain succinic semialdehyde reductase and is responsible for the reduction of succinic semialdehyde to gamma-hydroxybutryate [107].”
BackgroundHasin, D., Aharonovich, E., Liu, X., Mamman, Z., Matseoane, K., Carr, L. G., & Li, T.-K. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200209000-00002 · Cited by 56
Yasunami, M., Kikuchi, I., Sarapata, D. E., & Yoshida, A. (1990) · Genomics · doi:10.1016/0888-7543(90)90535-3 · Cited by 56 · cited 1×
“All known isoenzymes (homodimeric and heterodimeric) have been isolated and purified to homogeneity [162, 163].”
BackgroundAcrolein Modifies Apolipoprotein A‐I in the Human Artery Wall
Shao, B., O’Brien, K. D., McDonald, T. O., Fu, X., Oram, J. F., Uchida, K., & Heinecke, J. W. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.046 · Cited by 54 · cited 1×
“Like HNE, acrolein also readily forms covalent adducts with nucleophilic sites in proteins, lipids and DNA and acrolein-modified proteins have been detected in oxidized LDL [34] and human atherosclerotic lesions [35].”
BackgroundLi, D., Ferrari, M., & Ellis, E. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.09.007 · Cited by 53 · cited 2×
“to be less susceptible to DNA damage, showing a decrease in mutation rate caused by HNE compared to control cells [111].”
BackgroundLyon, R. C., Li, D., McGarvie, G. M., & Ellis, E. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.007 · Cited by 53 · cited 1×
“Based on these results, it was proposed that the reduction of aldehydes to alcohols by AKRs may represent an important detoxification route within neuronal cells further highlighting the potential for the interventional upregulation of AKRs via non-toxic derivatives or natural compounds representing a novel therapeuti…”
BackgroundKing, G. J., & Holmes, R. S. (1998) · Journal of Experimental Zoology · doi:10.1002/(sici)1097-010x(199809/10)282:1/2<12::aid-jez4>3.0.co;2-q · Cited by 52 · cited 1×
“In the epithelium of the human lens there is a high level of ALDH1A1 and a low level of ALDH3A1, thus a functional role of ALDH1A1 in the detoxification of aldehydes generated through the action of UV light has been described [123].”
BackgroundXiao, T., Shoeb, M., Siddiqui, M. S., Zhang, M., Ramana, K. V., Sk, S., Vasiliou, V., & Ansari, N. H. (2009) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390802706371 · Cited by 51 · cited 1×
“5 μM for HNE and MDA respectively [125].”
BackgroundMartinez, A., Aigueperse, C., Val, P., Dussault, M.-È. M., Tournaire, C., Berger, M., VEYSSIERE, G., Jean, C., & Lefrançois‐Martinez, A. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00244-1 · Cited by 50 · cited 1×
“Two major substrates of the enzyme have been identified: isocaproaldehyde and HNE (Table 1) [76].”
BackgroundAigueperse, C., Martinez, A., Lefrançois-Martinez, A.-M., VEYSSIERE, G., & Jean, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600147 · Cited by 50 · cited 1×
“AKR1B7—AKR1B7, also known as the mouse vas deferens protein, is expressed in the vas deferens [71], adrenal cortex [72, 73], and the ovarian theca cells [74].”
BackgroundLopes-Virella, M. F., Hunt, K. J., Baker, N. L., Virella, G., & Moritz, T. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.006 · Cited by 49
Tirard, J., Gout, J., Lefrançois‐Martinez, A., Martinez, A., Bégeot, M., & Naville, D. (2007) · Endocrinology · doi:10.1210/en.2006-1707 · Cited by 47 · cited 1×
“Interestingly, AKR1B7 is also present in white adipose tissue [77] and is associated with a higher ratio of pre-adipocytes vs adipocytes, where it might be linked to an inhibition of adipogenesis.”
BackgroundNADPH binding to β-subunit regulates inactivation of voltage-gated K+ channels
Tipparaju, S. M., Liu, S., Barski, O. A., & Bhatnagar, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.102 · Cited by 44
Self-citationAldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development
Gasparetto, M., Sekulovic, S., Brocker, C. N., Tang, P., Zakaryan, A., Xiang, P., Kuchenbauer, F. C., Wen, M., Kasaian, K., Witty, M. F., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.12.006 · Cited by 44
In vivo role of aldehyde reductase
Takahashi, M., Miyata, S., Fujii, J., Inai, Y., Ueyama, S., Araki, M., Soga, T., Fujinawa, R., Nishitani, C., Ariki, S., et al. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.003 · Cited by 44 · cited 1×
“The enzyme catalyzes the reduction of D-glucuronic acid and D-glucurono-γ-lactone during ascorbic acid biosynthesis and genetic deletion of this enzyme in mice results in severe osteopenia and spontaneous fractures due to ascorbic acid deficiency [53, 54].”
BackgroundCharacterisation of a novel mouse liver aldo‐keto reductase AKR7A5
Hinshelwood, A., McGarvie, G. M., & Ellis, E. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02982-4 · Cited by 43
Letter to the Editors: Corneal Aldehyde Dehydrogenase Displays Antioxidant Properties
Uma, L., JAYARAM, H., Sharma, Y., & Balasubramanian, D. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0098 · Cited by 42
Detoxication of the environmental pollutant acrolein by a rat liver aldo-keto reductase
GARDNER, R. A., Kazi, S., & Ellis, E. M. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.056 · Cited by 42 · cited 7×
“Furthermore, it was demonstrated that AKR7A1 is capable of detoxifying aflatoxin B1 (AFB1), a hepatocarcinogen [104, 105].”
BackgroundInfluentialTipparaju, S. M., Li, X., Kilfoil, P. J., Xue, B., Uversky, V. N., Bhatnagar, A., & Barski, O. A. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1093-z · Cited by 40 · cited 1×
“NADP(H) binding appears to be essential for the optimal interaction between Kv α and β subunits and for Kvβ-induced inactivation of Kv currents [92] and for the differential regulation of Kv currents by oxidized and reduced cofactor [93].”
BackgroundSelf-citationAcrolein-conjugated low-density lipoprotein induces macrophage foam cell formation
Watanabe, K., Nakazato, Y., Saiki, R., Igarashi, K., Kitada, M., & Ishii, I. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.020 · Cited by 39 · cited 1×
“Indeed, the uptake of acrolein-modified LDL by the SR-A1 receptors (scavenger receptor class A type 1) has been implicated in the formation of foam cells, which constitute the characteristics fatty streaks of early atherosclerotic lesions in the affected arteries [36].”
BackgroundTissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
Pratt–Hyatt, M., Lickteig, A. J., & Klaassen, C. D. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.051904 · Cited by 38 · cited 1×
“It is involved in the reduction of biogenic and xenobiotic aldehydes and is present in most tissues [49, 50].”
BackgroundCharacterization of the Human Aldehyde Reductase Gene and Promoter
Barski, O. A., Gabbay, K. H., & Bohren, K. M. (1999) · Genomics · doi:10.1006/geno.1999.5915 · Cited by 38 · cited 1×
“It is involved in the reduction of biogenic and xenobiotic aldehydes and is present in most tissues [49, 50].”
BackgroundRuiz, F. X., Moro, A., Gallego, O., Ardèvol, A., Rovira, C., Petrash, J. M., Parés, X., & Farrés, J. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.02.007 · Cited by 38
Shibata, T., Shimozu, Y., Wakita, C., Shibata, N., Kobayashi, M., Machida, S., Kato, R., Itabe, H., Zhu, X., Sayre, L. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187047 · Cited by 38 · cited 1×
“ONE-derived 4-ketoamide adducts have been observed in atherosclerotic lesions, suggesting a role in inflammation-related disease pathogenesis [26].”
BackgroundKelly, V. P., Ireland, L. S., Ellis, E. M., & Hayes, J. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480389 · Cited by 37
腫ようマーカーAKR1B10の高いall‐trans‐レチンアルデヒドレダクターゼ活性に対する構造的基礎
Gallego, O., Ruiz, F. X., Ardèvol, A., Marta, D., Álvarez, R., Angel, R. D. L., Rovira, C., Farrés, J., Ignacio, F., & Parés, X. (2007) · Proceedings of the National Academy of Sciences · Cited by 36
Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis
Li, D., Hinshelwood, A., GARDNER, R. A., McGarvie, G. M., & Ellis, E. M. (2006) · Toxicology · doi:10.1016/j.tox.2006.06.013 · Cited by 35 · cited 1×
“It was also demonstrated that the number of spontaneous mutations in AKR7A5 was lower than control cells even without treatment with HNE suggesting decreased sensitivity to endogenous mutations [112].”
BackgroundNovel lipid hydroperoxide‐derived hemoglobin histidine adducts as biomarkers of oxidative stress
Yocum, A. K., Oe, T., Yergey, A. L., & Blair, I. A. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.847 · Cited by 34 · cited 1×
“In the absence of an available residues such as lysine, the ONE-derived 4-ketoaldehydes can cyclize to give furans [24].”
BackgroundLuo, X., Liu, B., Ma, Q., & Peng, J. (2014) · Current Drug Targets · doi:10.2174/1389450115666140828142401 · Cited by 33 · cited 1×
“Interestingly, a newly identified ALDH2 activator, Alda-1 (Alda-1 is an agonist and a chemical chaperone for the common human aldehyde dehydrogenase 2 variant) demonstrated beneficial effects on heart and brain I/R injuries [139].”
BackgroundReductive detoxification of acrolein as a potential role for aldehyde reductase (AKR1A) in mammals
Kurahashi, T., Kwon, M., Homma, T., Saito, Y., Lee, J. Y., Takahashi, M., Yamada, K., Miyata, S., & Fujii, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.072 · Cited by 31 · cited 4×
“In addition, acrolein-induced protein modification and ER stress were also attenuated in ARK1A1 transgenic MEFs [55].”
BackgroundInfluentialVasiliou, V., Reuter, S. F., Kozak, C. A., & Nebert, D. W. (1993) · Pharmacogenetics · doi:10.1097/00008571-199312000-00002 · Cited by 30
Danielsson, O., Shafqat, J., Estonius, M., & JÖRNVALL, H. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1081b.x · Cited by 30 · cited 1×
“A number of gene loci encoding for human ADHs have been characterized [165, 166].”
BackgroundKaiser, R., Fernández, M. R., Parés, X., & Jörnvall, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11222 · Cited by 29 · cited 1×
“ADH2 exhibits high activity for ethanol oxidation and plays a major role in oxidative ethanol degradation [169].”
BackgroundGene Expression of the Mouse Corneal Crystallin Aldh3a1 : Activation by Pax6, Oct1, and p300
Davis, J. A., Davis, D. L., Norman, B., & Piatigorsky, J. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1057 · Cited by 29
Li, D., & Ellis, E. M. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.02.010 · Cited by 25 · cited 1×
“, a direct protective effect of AKR7A5 against oxidative stress induced using H2O2 and menadione was observed [113].”
BackgroundOng, W., Jenner, A. M., Pan, N., Ong, C. N., & Halliwell, B. B. (2009) · Free Radical Research · doi:10.1080/10715760802691455 · Cited by 23 · cited 1×
“HNE can also be generated from phospholipids associated with lipoproteins and cholesterol consumption thereby leading to a further increase in its production [13].”
BackgroundWang, J., Fang, Q., Dj, S., Chen, J., Xl, Z., Gw, L., Hz, L., & Fei, J. (2001) · PubMed · Cited by 23
AKR1B7 (mouse vas deferens protein) is dispensable for mouse development and reproductive success
Baumann, C., Davies, B., Peters, M., Kaufmann-Reiche, U., Lessl, M., & Theuring, F. (2007) · Reproduction · doi:10.1530/rep-07-0022 · Cited by 22 · cited 1×
“AKR1B7—AKR1B7, also known as the mouse vas deferens protein, is expressed in the vas deferens [71], adrenal cortex [72, 73], and the ovarian theca cells [74].”
BackgroundKotokorpi, P., Gardmo, C., Nyström, C. S., & Mode, A. (2004) · Endocrinology · doi:10.1210/en.2004-0552 · Cited by 21 · cited 7×
“AKR1B7 has an ortholog in rats; AKR1B14, and shares up to 87% sequence identity.”
BackgroundInfluentialLi, D., & Ellis, E. M. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.015 · Cited by 21 · cited 16×
“AKR7A2—”
BackgroundInfluentialMass spectrometric evidence for long-lived protein adducts of 4-oxo-2-nonenal
Zhu, X., & Sayre, L. M. (2007) · Redox Report · doi:10.1179/135100007x162176 · Cited by 20
Catalytic reduction of carbonyl groups in oxidized PAPC by Kvβ2 (AKR6)
Xie, Z., Barski, O. A., Cai, J., Bhatnagar, A., & Tipparaju, S. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.032 · Cited by 16 · cited 1×
“These results suggested that Kvβ could serve as a sensor of lipid-oxidation via its catalytic activity and thereby alter Kv currents under conditions of oxidative stress [95, 96].”
BackgroundSelf-citation[Classification of alcohol metabolizing enzymes and polymorphisms--specificity in Japanese].
Harada, S. (2001) · PubMed · Cited by 16
Kinetics of nucleotide binding to the β-subunit (AKR6A2) of the voltage-gated potassium (Kv) channel
Barski, O. A., Tipparaju, S. M., & Bhatnagar, A. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.016 · Cited by 12 · cited 1×
“These results suggested that Kvβ could serve as a sensor of lipid-oxidation via its catalytic activity and thereby alter Kv currents under conditions of oxidative stress [95, 96].”
BackgroundSelf-citationKorkalainen, M., Törrönen, A., & Kärenlampi, S. O. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03325-3 · Cited by 12
Höög, J., Estonius, M., & Danielsson, O. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_30 · Cited by 9 · cited 2×
“Class I ADHs are widespread but show significant variability in activities across different tissues [168].”
BackgroundCanuto, R. A., Maggiora, M., Trombetta, A., Martinasso, G., & Muzio, G. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00169-2 · Cited by 9
Carbonyl Toxification Hypothesis of Biological Aging
Yin, D., & Brunk, U. T. (2017) · CRC Press eBooks · doi:10.1201/9780203711309-16 · Cited by 7 · cited 1×
“Among the many products of lipid-peroxidation, RCS such as formaldehyde, acetaldehyde, acrolein, MDA, glyoxal, and methylglyoxal have received much attention as the potential oxidants that contribute to pathological changes under a variety of disease conditions [176, 177].”
Background
Cited by
Oxidative Stress and Antioxidant Metabolism under Adverse Environmental Conditions: a Review
García-Caparrós, P., De Filippis, L., Gul, A., Hasanuzzaman, M., Ozturk, M., Altay, V., & Lao, M. T. (2021) · The Botanical Review · doi:10.1007/s12229-020-09231-1 · Cited by 555
DNA damage by lipid peroxidation products: Implications in cancer, inflammation and autoimmunity
Gentile, F., Arcaro, A., Pizzimenti, S., Daga, M., Cetrangolo, G. P., Dianzani, C., Lepore, A., Graf, M., Ames, P. R. J., & Barrera, G. (2017) · AIMS Genetics · doi:10.3934/genet.2017.2.103 · Cited by 205
Metadata
- Authors
- Singh, M., Kapoor, A., & Bhatnagar, A.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 234
- Pages
- 261-273
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2085067380
- Cited by
- 163
- References
- 158
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.